News
-
-
-
COMMUNIQUÉ DE PRESSE
Formycon expands commercial portfolio: Aflibercept biosimilars Ahzantive® and Baiama® are now available in the European Union
Formycon expands commercial portfolio with the launch of Aflibercept biosimilars Ahzantive(R) and Baiama(R) in the European Union, reinforcing market penetration and growth strategy -
-
COMMUNIQUÉ DE PRESSE
NanoViricides Announces Closing of ~$2 Million Registered Direct Offering
NanoViricides, Inc. announces closing of $2M direct offering. Exclusive placement agent D. Boral Capital LLC. SEC registration effective. NV-387, a revolutionary antiviral drug granted Orphan Drug Designation -
COMMUNIQUÉ DE PRESSE
Bridging Global Markets: Cathay Cargo Redefines Cold Chain Excellence via Hong Kong’s Strategic Nexus
Cathay Cargo enhances logistics with Cold Chain solutions for Greater Bay Area and global markets. Total Cold Chain Vision ensures precision and speed for perishables and pharmaceuticals -
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Résultats de l’offre publique de retrait et mise en œuvre du retrait obligatoire à venir sur les titres TERACT
Résultats offre publique de retrait TERACT par InVivo Group, mise en œuvre du retrait obligatoire à venir suite à l'Offre clôturée le 13 mai 2026. Détention de 99,62% du capital -
COMMUNIQUÉ RÉGLEMENTÉ
Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
InVivo Group completes public buy-out offer of TERACT shares acquiring majority control, initiates squeeze-out. AMF to oversee procedure. TERACT, a key player in responsible distribution markets, now part of InVivo's network of brands
